Viewing Study NCT01656720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-04-15 @ 2:48 PM
Study NCT ID: NCT01656720
Status: COMPLETED
Last Update Posted: 2015-06-09
First Post: 2012-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
Sponsor: Norgine
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-02
Start Date Type: None
Primary Completion Date: 2013-12
Primary Completion Date Type: ACTUAL
Completion Date: 2014-09
Completion Date Type: ACTUAL
First Submit Date: 2012-08-01
First Submit QC Date: None
Study First Post Date: 2012-08-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-06-08
Last Update Post Date: 2015-06-09
Last Update Post Date Type: ESTIMATED